Effect of suramin on squamous differentiation and apoptosis in three human non-small cell lung cancer cell lines

Journal of Cellular Biochemistry

Volumn 62, Issue SUPPL. 24, 1996, Pages 186-197

  Lokshin, Anna ^a   Levitt, Mark L ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

apoptosis; lung cancer; squamous differentiation; suramin

Indexed keywords

PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SURAMIN; ANTINEOPLASTIC AGENT; CALCIMYCIN; DNA FRAGMENT; ENZYME INHIBITOR; INVOLUCRIN; IONOPHORE; PROTEIN KINASE C; PROTEIN PRECURSOR; PUTRESCINE; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA DEGRADATION; DOSE RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; CELL CULTURE; CELL DIVISION; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; LUNG TUMOR; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; CALCIMYCIN; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL DIVISION; DNA FRAGMENTATION; ENZYME INHIBITORS; HUMANS; IONOPHORES; LUNG NEOPLASMS; NEOPLASM PROTEINS; PROTEIN KINASE C; PROTEIN PRECURSORS; PUTRESCINE; SURAMIN; TRANSGLUTAMINASES; TUMOR CELLS, CULTURED;

EID: 33646965900     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.240630514     Document Type: Article

References (54)

1. Minna JD, Pass J, Gladstein E, Ihde DC (1989): Cancer of the lung. In De Vita VT Jr, Hellman S, Rosenberg SA (eds): "Cancer: Principles and Practice of Oncology." Philadelphia: J.B. Lippincott, pp 591-705.
2. Ihde DC, Minna JD (1991): Non-small cell lung cancer. Part I: Biology, diagnosis and staging. Curr Prob Cancer March/April:63-104.
3. Pierce GB, Speers WC (1988): Tumors as caricatures of the process of tissue renewal: Prospects for therapy by directing differentiation. Cancer Res 48:1996-2004.
4. Seifter EJ, Levitt ML, Kramer BS (1987): An outlier theory of cancer curability: Tumor cell differentiation as a therapeutic goal. Am J Med 83:757-760.
5. Yamamoto E, Nakagawa K, Fujimoto E, Muroki T, Kumagai S, Kojima S, Tkatsuka S (1989): Histological malignancy grading of oral squamous cell carcinomas. Gan No Rinsho 35:1665-1672.
6. Green H (1979): The keratinocyte as differentiated cell type. Harvey Lect 74:101-139.
7. Eckert RL (1989): Structure, function, and differentiation of the keratinocytes. Physiol Rev 69:1316-1346.
8. Jetten AM (1989): Multistep process of squamous differentiation in tracheobronchial epithelial cells in vitro: Analogy with epidermal differentiation. Environ Health Perspect 80:149-160.
9. Levitt ML, Gazdar AF, Oie HK, Schuller H, Thacher SM (1990): Cross-linked envelope related markers for squamous differentiation in human lung cancer cell lines. Cancer Res 50:120-128.
10. Haake AR, Polakowska RR (1993): Cell death by apoptosis in epidermal biology. J Invest Dermatol 101:107-112.
11. Fesus L, Thomazy V, Autuori P, Ceru MP, Tarcsa E, Piacentini M (1989): Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action. FEBS Lett 245:150-154.
12. Piacentini M, Autuori F, Dini L, Farrace MG, Ghibelli L, Piredda L, Fesus L (1991): "Tissue" transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factor stimulation. Cell Tissue Res 263:227-235.
13. Greenberg CS, Birkbichler PJ, Rice RH (1991): Transglutaminases: Multifunctional cross-linking enzymes that stabilize tissues. FASEB J 5:3071-3077.
14. Eckert RL, Green H (1986): Structure and evolution of human involucrin gene. Cell 46:583-589.
15. Simon M, Green H (1985): Enzymatic cross-linking of involucrin and other proteins by keratinocyte particulates in vitro. Cell 40:677-683.
16. Tarcsa E, Kedei N, Thomazy V, Fesus L (1992): An involucrin-like protein in hepatocytes serves as a substrate for tissue transglutaminase during apoptosis. J Biol Chem 267:25648-25651.
17. McCall CA, Cohen JJ (1991): Programmed cell death in terminally differentiating keratinocytes: Role of endogenous endonuclease. J Invest Dermatol 97:111-114.
18. Hockenbery D, Zutter M, Hickey W, Nahm M, Korsmeyer M (1991): BCL-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88:6961-6965.
19. Waltz TM, Abdiu A, Wingren S, Smeds S, Larsson S-E, Wasteson A (1991): Suramin inhibits growth of human osteosarcoma xenografts in nude mice. Cancer Res 51: 3585-3589.
20. La Rocca RV, Danesi R, Cooper MR, Jamis-Dow CA, Ewing MW, Lihehan WM, Myers CE (1991): Effect of suramin on human prostate cancer cells in vitro. J Urol 145:393-398.
21. Fantini J, Rognoni J-B, Roccabianca M, Pommier G, Marvaldi J (1989): Suramin inhibits cell growth and glycolytic activity and triggers differentiation of human colic adenocarcinoma cell clone HT29-D4. J Biol Chem 264:10282-10286.
22. Johansson A, Rorsman F, Forsberg K, Betsholtz C, Bergh J (1990): Human non-small cell lung cancer cell lines express platelet-derived growth factor (PDGF) and transforming growth factors (TGF), and suramin induces growth inhibition of these cell lines. Anticancer Res 10:1373-1374.
23. Morocz IA, Lauber B, Schmitter D, Stahel RA (1993): In vitro effect of suramin on lung tumor cells. Eur J Cancer 29A:245-247.
24. Cardinali M, Sartor O, Robbins KC (1992): Suramin, an experimental chemotherapeutic drug, activates the receptor for epidermal growth factor and promotes growth of certain malignant cells. J Clin Invest 89:1242-1247.
25. Foekens JA, Sieuwerts AM, Stuurman-Smeets MJ, Dorssers LCJ, Berns EMJJ, Klijn JGM (1992): Pleiotropic actions of suramin on the proliferation of human breast-cancer cells in vitro. Int J Cancer 51:439-444.
26. Coffey RJ, Leof EB, Shipley GD, Moses HL (1987): Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J Cell Physiol 132: 143-148.
27. Lechner JF, MaClendon IA, LaVeck MA, Shamsuddin AM, Harris CC (1983): Differential control by platelet factors of squamous differentiation in normal and malignant human bronchial epithelial cells. Cancer Res 43: 5915-5921.
28. Hensey CE, Boskoboinik D, Azzi A (1989): Suramin, an anticancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2A. FEBS Lett 258:156-163.
29. Clemens MJ, Trayner I, Menaya J (1992): The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation. Eur J Cell Sci 103:881-887.
30. Araki S, Simada Y, Kaji K, Hayashi H (1990): Role of protein kinase C in the inhibition by fibroblast growth factor of apoptosis in serum-depleted endothelial cells. Biochem Biophys Res Commun 172:1081-1085.
31. Sartor O, McLellan CA, Myers CE, Borner MM (1992): Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines. J Clin Invest 90:2166-2174.
32. Ono K, Nakane H, Fukushima M (1988): Differential inhibition of various deoxyribonucleic and ribonucleic acid polymerases by suramin. Eur J Biochem 172:349-353.
33. Bojanowski K, Lelievre S, Markovits J, Couprie J, Jacquemin-Sablon A, Kragh Larsen A (1992): Suramin is an inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells. Proc Natl Acad Sci USA 89:3025-3029.
34. Pommier GJ, Garrouste FL, El Atiq F, Roccabianca M, Marvaldi JL (1992): Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line. Cancer Res 52:3182-3188.
35. Horne MK III, Stein CA, La Rocca RV, Myers CE (1988): Circulating glycosaminoglycan anticoagulants associated with suramin treatment. Blood 71:273-279.
36. Constantopoulos G, Rees S, Cragg BG, Barranger JA, Brady RD (1980): Experimental animal model for mucopolysacharidosis: Suramin-induced glycosaminoglycan and sphingolipid accumulation in the rat. Proc Natl Acad Sci USA 77:3700-3704.
37. Chakravarty R, Rice RH (1989): Acylation of keratinocyte transglutaminase by palmitic and myristic acids in the membrane anchorage region. J Biol Chem 264:625-629.
38. Lokshin AE, Mayotte J, Levitt ML (1993): Mechanism of interferon-β stimulated cross-linked envelope competence in human squamous carcinoma of the lung. Proc Am Assoc Can Res 34:3117.
39. Folk JE, Park MH, Chung SI, Schrode J, Lester EP, Cooper HL (1980): Polyamines as physiological substrates for transglutaminases. J Biol Chem 225:3695-3700.
40. Martin SJ, Lennon SV, Bonham AM, Cotter TG (1990): Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J Immunol 145:1858-1867.
41. Ledda-Columbano GM, Coni P, Faa G, Manenti G, Columbano A (1992): Rapid induction of apoptosis in rat liver by cycloheximide. Am J Pathol 140:545-549.
42. Kim HC, Lewis MS, Gorman JJ, Park SC, Girard JE (1990): Protransglutaminase E from guinea pig skin. Isolation and partial characterization. J Biol Chem 265: 21271-21278
43. Knight CRL, Rees RC, Elliott BM, Griffin M (1990): The existence of an inactive form of transglutaminase within metastasizing tumors. Biochim Biophys Acta 1053: 13-20.
44. Chakravarty R, Rong X, Rice RH (1990): Phorbol ester-stimulated phosphorylation of keratinocyte transglutaminase in the membrane anchorage region. Biochem J 271:25-30.
45. 2+ by platelet-derived growth factor with mitogenesis but not with proteoglycan synthesis in chondrocytes: Effect of suramin. Cell Calcium 10:29-35.
46. Jiang H, Kochnar DM (1992): Induction of tissue transglutaminase and apoptosis by retinoic acid in the limb bud. Teratology 46:333-340.
47. Bursch W, Paffe S, Putz B, Bartel G, Schulte-Hermann R (1990): Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis 11:847-853.
48. Gazdar AF, Carney DN, Nau MM, Minna JD (1985): Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Cancer Res 45:2924-2930.
49. Colombel M, Olsson CA, Ng PY, Buttyan R (1992): Hormone-regulated apoptosis results from the reentry of differentiated prostate cell onto a defective cell cycle. Cancer Res 52:4313-4319.
50. White E (1993): Death-defying acts: A meeting review on apoptosis. Genes Dev 7:2277-2284.
51. McConkey DJ, Orrenius S, Jondal M (1990): Cellular signalling in programmed cell death (apoptosis). Immunol Today 11:120-121.
52. Raff MC (1992): Social control of cell survival and cell death. Nature 356:397-399.
53. Kim JH, Sherwood ER, Sutkowsky DM, Lee C, Kozlowsky J (1991): Inhibition of pro static tumor cell proliferation by suramin: Alterations in TGF alpha-mediated autocrine growth regulation and cell cycle distribution. J Urol 146:171-176.
54. Ewing MW, Liu SC, Gnarra JR, Walther MM, Meyers CE, Linehan WM (1993): Effect of suramin on the mitogenic response of the human prostate carcinoma cell line PC-3. Cancer 71:1151-1158.